GLP-1 Drug Names: Branded & Compounded Options Explained

GLP-1 receptor agonists include semaglutide, tirzepatide, retatrutide, liraglutide, dulaglutide, and exenatide—each with distinct mechanisms, dosing schedules, and clinical profiles. These medications work by mimicking glucagon-like peptide-1, a hormone regulating blood sugar and appetite.

Knowing GLP-1 drug names is only the first step. Your genetic makeup, biomarker profile, and metabolic characteristics may influence how your body responds to different agents. PlexusDx emphasizes precision selection, combining drug knowledge with personalized genetic and clinical insights to support more targeted provider conversations.

Major GLP-1 Medications: Branded and Compounded Forms

Branded semaglutide (Ozempic for diabetes, Wegovy for weight loss) is administered weekly via injection. Compounded semaglutide offers similar dosing flexibility at lower cost, sourced from licensed 503A pharmacies. Oral semaglutide (Rybelsus) is taken daily and may suit patients preferring tablets over injections.

Tirzepatide (branded Mounjaro for diabetes, Zepbound for weight management) is a dual GIP/GLP-1 agonist given weekly. Compounded tirzepatide provides equivalent formulations through compounding pharmacies. Retatrutide, a newer triple hormone agonist, remains primarily in clinical development but represents emerging GLP-1 class expansion.

GLP-1 Drug Names and Their Mechanisms: A Comparison Framework

Each GLP-1 drug name corresponds to a specific mechanism and receptor profile. Understanding these differences helps clarify why your provider might recommend one over another based on your clinical history, metabolic markers, and treatment goals.

Why GLP-1 Drug Name Matters: Dosing, Duration, and Onset

Different GLP-1 drug names carry different dosing schedules and pharmacokinetics. Semaglutide and tirzepatide offer convenient weekly dosing; liraglutide and exenatide require daily or weekly injections. Onset of action varies—some agents begin lowering glucose within hours, while sustained weight loss typically emerges over weeks to months.

Your provider considers onset profile and dosing frequency alongside your lifestyle, comorbidities, and medication adherence capacity. Compounded versions of semaglutide and tirzepatide maintain the same active ingredients and dosing schedules as branded counterparts, offering cost-effective alternatives without sacrificing efficacy when sourced from licensed 503A pharmacies.

How Genetic Factors May Influence Your Response to GLP-1 Drug Names

Your response to any GLP-1 drug name—whether semaglutide, tirzepatide, or others—is partly shaped by genetic variations in GLP-1 receptor function, GIP signaling, and metabolism. Key variants like GLP1R rs6923761 and GIPR rs1800437 may provide context for individual variability in weight loss and glucose response.

PlexusDx's Precision Peptide Genetic Test examines predispositions in peptide pathway genes including GLP1R, GIPR, FTO, and MC4R. This test should not be interpreted as predicting exact medication response, but rather as helping provide context that may support a more informed conversation with your healthcare provider about which GLP-1 drug name aligns with your metabolic profile.

Safety Considerations and Provider Guidance for GLP-1 Selection

All GLP-1 drug names carry similar safety profiles: nausea, vomiting, and gastrointestinal disturbances are common early side effects. Rare but serious risks include pancreatitis, thyroid C-cell concerns (primarily animal data), and retinopathy in diabetic patients. Pregnancy, personal thyroid cancer history, and severe renal impairment are contraindications.

Your provider evaluates contraindications, concomitant medications, and your specific clinical goals before recommending a particular GLP-1 drug name. Compounded semaglutide and tirzepatide carry the same safety profile as branded versions but should only be used under medical supervision. Regular monitoring for efficacy and adverse effects remains essential regardless of which GLP-1 medication is selected.

How PlexusDx Supports a More Personalized Approach

PlexusDx recognizes that GLP-1 drug names represent a range of mechanisms and potencies. Your genetic predispositions in GLP-1 receptor expression, GIP signaling capacity, and appetite regulation genes may help provide context for why certain drug names might be discussed by your provider. These insights should be interpreted with a qualified healthcare provider as part of a comprehensive assessment.

The Precision Peptide Genetic Test reveals predispositions in four key pathways: GLP1R (GLP-1 receptor sensitivity), GIPR (GIP co-receptor function), FTO (metabolic regulation), and MC4R (appetite signaling). These variants do not determine which GLP-1 drug name will work best, but they may contextualize your metabolic tendencies and support a more personalized conversation about medication selection.

Understanding GLP-1 drug names alongside your genetic profile empowers you to have deeper, more informed discussions with your provider about why a specific agent—whether branded semaglutide, compounded tirzepatide, or another option—might align with your metabolic and clinical characteristics. Genetic context is one tool among many in precision wellness.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

• Maximus Glp 1
• Found Glp 1
• Orderly Meds Glp 1
• Henry Meds Glp 1